Document is current
Any future updates will be listed below
-
Authors
Thawani, Akanksha https://orcid.org/0000-0003-4168-128X
Florez Ariza, Alfredo Jose https://orcid.org/0000-0003-2429-4659
Nogales, Eva https://orcid.org/0000-0001-9816-3681
Collins, Kathleen
- License Information
-
More Information
Article History
Received: 14 April 2023
Accepted: 4 December 2023
First Online: 14 December 2023
Change Date: 1 May 2025
Change Type: Update
Change Details: In the version of this article initially published, the last name of Alfredo Jose Florez Ariza was listed incorrectly in the metadata (as Ariza and not Florez Ariza), and is now amended in the HTML version of the article.
Competing interests
: K.C. is an equity holder and scientific advisor for Addition Therapeutics, which uses a different retrotransposon protein for gene therapy technology. UC Berkeley has filed a provisional patent application on L1 ORF2p RNP engineering with all of the authors listed as inventors.
